Sign in
Enrolling by invitationNo phase

Data hub collecting health information from people with blood diseases

Collects health records from people with sickle cell disease or multiple myeloma.

Key facts

Who runs it
ASH Research Collaborative
Where
Washington D.C., United StatesSee the site
Trial code
Registry title
ASH Research Collaborative Data Hub
Status
Enrolling by invitation
People taking part
100,000 people, planned
Started
29 Apr 2020
Expected to end
29 Apr 2099
Type of study
Observational, 2 groups
Record updated
17 June 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with documented sickle cell disease or active multiple myeloma. The records go back to 2015.

Sex
All sexes can join.
Disease stage
Documented sickle cell disease and/or active multiple myeloma since 2015.

The registry criteria, word for word

Show the criterionShow less

Other criteria

  • To be included in the Data Hub, patients must have documented sickle cell disease and/or active multiple myeloma since 2015

Where in United States

  • ASH Research CollaborativeWashington D.C., United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Benign and malignant hematologic diseases are relatively rare conditions within the spectrum of medical practice in any one site of care. Nonetheless, recent research in hematologic conditions from basic, translational, clinical and population perspectives offer the possibility of improving the way that these diseases are treated, and the outcomes experienced by patients. A repository that aggregates and validates this data across institutions and other practice settings is needed in order to identify variation in care, new findings, and further research.

The 2 groups in the trial

  • Sickle Cell Disease
  • Multiple Myeloma

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologic Disease
Plain-language title
Data hub collecting health information from people with blood diseasesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
17 June 2024